≡ Risteys
R9

Documentation Changelog GitHub Contact & Feedback

Persistent hyperplasia of thymus

DOID MESH PheWeb

E4_HYPERTHY

No definition available.

Endpoint definition

↥
FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 E32.0
Hospital discharge: ICD-9 2540
Cause of death: ICD-10 E32.0
Cause of death: ICD-9 2540

2 out of 7 registries used, show all original rules.

23

diagram downward connector

Check minimum number of events None

23

diagram downward connector

Include endpoints None

23

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

23

diagram downward connector
E4_HYPERTHY

Control definitions

Control exclude E4_ENDOGLAND

Extra metadata

Level in the ICD hierarchy 4
First used in FinnGen datafreeze DF2
Parent code in ICD-10 E32
Name in latin Hyperplasia thymi persistens

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 23 11 12
Unadjusted prevalence (%) 0.01 0.01 0.01
Mean age at first event (years) 51.98 55.20 49.03

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: E4_HYPERTHY – Persistent hyperplasia of thymus
GWS hits:

Survival analyses between endpoints

↥

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Persistent hyperplasia of thymus

↥

Endpoint not on priority list, no data to show.